Guillaume Canaud

6PUBLICATIONS
42CO-AUTHORS
Haematological tumoursNeurology and neuromuscular diseasesTerahertz physicsHypersonic propulsion and hypersonic aerothermodynamicsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 01, 2026
Oncogenic PIK3CA mutations shape an immunoregulatory microenvironment in mosaic overgrowth disorders.

|Nov 22, 2025
Vascular malformations: from genetics to therapeutics.

Gabriel Morin, Ilaria Galasso, Guillaume Canaud

|Jun 24, 2025
PIK3CA gain-of-function mutation in Schwann cells leads to severe neuropathy and aerobic glycolysis through a non-cell autonomous effect.

Quitterie Venot, Marina Firpion, Sophia Ladraa

|Jun 06, 2025
First report of successful pregnancies after treatment with alpelisib for PIK3CA-related overgrowth spectrum.

Gabriel Morin, Antoine Fraissenon, Caroline Chopinet

|May 19, 2025
Somatic PIK3R1 mutations in the iSH2 domain are accessible to PI3Kα inhibition.

Gabriel Morin, Alexandre P Garneau, Nabiha Bouzakher

|Sep 15, 2023
Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibition.

Charles Bayard, Eleonora Segna, Maxime Taverne

Pageof 1

Frequent Collaborators

4 joint publications

Antoine Fraissenon

3 joint publications

Gabriel Morin

3 joint publications

Nicolas Goudin

3 joint publications

Patrick Villarese